OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations
// Maria E. Riveiro 1 , Lucile Astorgues-Xerri 1 , Ramiro Vazquez 2 , Roberta Frapolli 2 , Ivo Kwee 3, 5 , Andrea Rinaldi 3 , Elodie Odore 6 , Keyvan Rezai 6 , Mohamed Bekradda 1 , Giorgio Inghirami 7, 9 , Maurizio D’Incalci 2 , Kay Noel 10 , Esteban Cvitkovic 1, 10 , Eric Raymond 11 , Francesco Bertoni 3, 12 1 Oncology Therapeutic Development, Clichy, France 2 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy 3 Lymphoma and Genomics Research Program, IOR Institute of Onc
OpenAlex
3553d ago
Biotech